| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0089 | 0.9 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |